#tempus-ai

[ follow ]
#semiconductors #ai-stocks #applovin #nvidia #ai-infrastructure #earnings-outlook #lithiumalbemarle #health-ai
from24/7 Wall St.
4 days ago

AppLovin Surges 11% While Tempus AI and Micron Also Outpace Most AI Stocks

AppLovin surged to lead the sector after Morgan Stanley raised its price target, maintaining an Overweight rating. That call centers on AppLovin's AXON AI engine, which powers its mobile advertising platform and has been the engine behind a remarkable earnings run. In Q4 2025, AppLovin reported revenue of $1.66 billion, up 66% year over year, with an adjusted EBITDA margin of 84%. Investors sold off the stock despite the strong results, but recent defense of its valuation from Wall Street has led to a bounceback.
Artificial intelligence
Business
from24/7 Wall St.
1 week ago

Market Movers: Citi Bullish on NVDA Heading into Earnings

NVIDIA poised for significant upside on AI-driven data-center demand, strong valuation, and Rubin architecture prospects; Tempus and Albemarle also received positive analyst actions.
Health
from24/7 Wall St.
3 months ago

This AI Health Stock is Up Over 150% This Year-and It's Not Slowing Down

Tempus AI offers an applied-health AI investment opportunity with high-growth potential, notable institutional investors, and a recent stock dip that may present a buying opportunity.
from24/7 Wall St.
9 months ago

TEMPUS (Nasdaq: TEM) Earnings: Live Coverage And What to Expect

Tempus AI, a leader in clinical AI and health data infrastructure, is poised for significant growth with a projected revenue of $1.24 billion in 2025.
Startup companies
[ Load more ]